이 페이지는 자동 번역되었으며 번역의 정확성을 보장하지 않습니다. 참조하십시오 영문판 원본 텍스트의 경우.

Acceptability, Feasibility and Impact of Oral HIV Self-testing for Partner Testing Among Kenyan Adolescent Girls Aged 15-19 Years: A Randomized Controlled Trial

2022년 7월 19일 업데이트: University of Pennsylvania
This randomized controlled trial will assess the feasibility, acceptability and impact of the provision of multiple oral-fluid based HIV self-test kits to HIV-negative adolescents aged 15-19 years to promote HIV testing among their sexual partners and couples testing.

연구 개요

상세 설명

This study will recruit HIV-negative adolescents girls (AG) aged 15-19 years in Siaya County, western Kenya. The study will evaluate the impact of the provision of oral HIV self-testing on uptake of testing among partners of adolescent girls. We will randomize about 300 sexually active AG to either an intervention group that receives multiple oral self-test kits that they can choose to offer to their sexual partner(s) or to a control group that will be given multiple referral coupons that their partners can use for HIV testing at pre-selected HIV testing services (HTS) sites. We will collect data on whether the kits were offered, to whom they were offered, if they were accepted, if they were used and with what results, if known, and if the partners who obtained HIV-positive results sought confirmatory testing. We will also conduct in-depth interviews with a sub-set adolescents to explore their experiences in offering HIV self-testing to their male partners.

This study has 4 specific aims: i) determine whether adolescent girls can safely offer oral HIV self-tests to their partners; ii) assess whether oral self-testing improves uptake of HIV testing among partners of adolescent girls; iii) document adverse events associated with offering oral self-testing to sexual partners of adolescent girls; and iv) qualitatively explore the experiences of adolescent girls when offering self-test kits to their partners.

연구 유형

중재적

등록 (실제)

349

단계

  • 해당 없음

연락처 및 위치

이 섹션에서는 연구를 수행하는 사람들의 연락처 정보와 이 연구가 수행되는 장소에 대한 정보를 제공합니다.

연구 장소

      • Kisumu, 케냐
        • Impact Research & Development Organization

참여기준

연구원은 적격성 기준이라는 특정 설명에 맞는 사람을 찾습니다. 이러한 기준의 몇 가지 예는 개인의 일반적인 건강 상태 또는 이전 치료입니다.

자격 기준

공부할 수 있는 나이

15년 (어린이, 성인)

건강한 자원 봉사자를 받아들입니다

연구 대상 성별

여성

설명

Inclusion Criteria:

  • Female
  • Aged 15-19 years
  • HIV-negative (willing to self-test onsite in the presence of the Research Assistant who is also a trained HIV counselor)
  • Has at least one current sexual partner she expects to meet at least twice in the next 3 months (not necessarily to have sex); this will provide opportunity for the participant to suggest/offer testing.
  • Resides in Siaya County and does not intend to relocate within 6 months from enrollment, to allow follow up to be completed and to conduct IDI with those selected.
  • Willing to be randomized into the partner self-testing or HTS referral groups.
  • Reporting no incident of sexual, physical, emotional, or economic abuse in the last 12 months from the partner she intends to offer (Appendix 4) or refer for testing (Appendix 3) in the next 3 months and does not believe the partner will abuse her if she offers the self-test kits or HTS referral coupon.
  • Has a male partner who has not tested for 6 months or whose HIV status is unknown to her.
  • Agrees to give consent to participate in the study.

Exclusion Criteria:

  • Male
  • HIV-positive
  • Not willing to self-test onsite under in the presence of the Research Assistant
  • Aged <15 years or >19 years
  • Does not have a current sexual partner or does not expect to meet the partner at least twice in the next 3 months
  • Does not reside in Siaya County or intends to relocate within the next 6 months
  • Not interested in obtaining HIV self-tests or HTS referral coupon for purposes of suggesting testing to their sexual partners
  • Reporting an incidence of sexual, physical, emotional or economic abuse in the last 12 months from the partner she would have offered self-test kit or referred for testing, or believes the partner may subject her to sexual, physical, emotional, or economic abuse if she offered them self-test kit or HTS coupon.
  • Has a male partner who tested within the last 6 months.
  • Does not give consent to participate in the study

공부 계획

이 섹션에서는 연구 설계 방법과 연구가 측정하는 내용을 포함하여 연구 계획에 대한 세부 정보를 제공합니다.

연구는 어떻게 설계됩니까?

디자인 세부사항

  • 주 목적: 방지
  • 할당: 무작위
  • 중재 모델: 병렬 할당
  • 마스킹: 없음(오픈 라벨)

무기와 개입

참가자 그룹 / 팔
개입 / 치료
실험적: Provision of multiple self-tests
Participants randomized to the intervention group will be given 2-3 HIV oral self-tests to offer to their sexual partner(s). The participant will be instructed to encourage their partner to test himself alone [partner testing] or with the participant [couple testing]; the partner will also be given a card with information on testing and a list of facilities where he can go for confirmatory testing. All participants will be encouraged to call a study helpline/hotline in the event of any adverse events that they or their sexual partners experience or if they need further instructions or information
Participants will be given multiple Oraquick Advance HIV-1/2 test kits to distribute to their sexual partners for partner testing or couple testing. Phone interviews will be conducted with the participants to assess whether they provided a HIV self-test to their partner, if the test was used, how it was used (partner testing or couple testing), if the partner disclosed his results, the partner's reaction to the results, and if the partner went for confirmatory testing
간섭 없음: Referral vouchers for clinic testing
Participants randomized to the control group will be given multiple referral coupons for HIV testing at pre-selected HIV testing services (HTS) sites. The participant will be instructed to give the coupon to their sexual partner(s) and encourage him to go for HIV testing at pre-selected HTS sites, either alone [partner testing] or together with the participant [couple testing]. The coupon will also have information on testing and a list of facilities where he can go for HTS. All participants will be encouraged to call a study helpline/hotline in the event of any adverse events that they or their sexual partners experience or if they need further instructions or information

연구는 무엇을 측정합니까?

주요 결과 측정

결과 측정
측정값 설명
기간
uptake of partner HIV testing
기간: 3 months
proportion of partners that complete HIV testing
3 months

2차 결과 측정

결과 측정
측정값 설명
기간
Introduce testing
기간: 3 months
proportion of participants who introduce testing to their partners
3 months
Partner accept testing
기간: 3 months
proportion of partners who were offered HIVST or referral coupon and accepted
3 months
Partner testing
기간: 3 months
proportion of participants who report their partner tested alone
3 months
Couples testing
기간: 3 months
proportion of participants who report testing with their partner
3 months
Positive partner
기간: 3 months
proportion of participants who report their partner test result was positive
3 months
linked to care
기간: 3 months
Proportion of participants who report their partners was linked to care
3 months
Intimate partner violence
기간: 3 months
proportion of participants in each study group who report intimate partner violence related to HIV testing
3 months
Confirmatory testing for positive HIV self-test
기간: 3 months
proportion of participants in the intervention group who report their partner tested positive and went for confirmatory testing
3 months

공동 작업자 및 조사자

여기에서 이 연구와 관련된 사람과 조직을 찾을 수 있습니다.

수사관

  • 수석 연구원: Kawango Agot, PhD, Impact Organization & Research Development

연구 기록 날짜

이 날짜는 ClinicalTrials.gov에 대한 연구 기록 및 요약 결과 제출의 진행 상황을 추적합니다. 연구 기록 및 보고된 결과는 공개 웹사이트에 게시되기 전에 특정 품질 관리 기준을 충족하는지 확인하기 위해 국립 의학 도서관(NLM)에서 검토합니다.

연구 주요 날짜

연구 시작 (실제)

2021년 3월 2일

기본 완료 (실제)

2021년 4월 19일

연구 완료 (실제)

2021년 7월 2일

연구 등록 날짜

최초 제출

2021년 3월 16일

QC 기준을 충족하는 최초 제출

2021년 3월 16일

처음 게시됨 (실제)

2021년 3월 18일

연구 기록 업데이트

마지막 업데이트 게시됨 (실제)

2022년 7월 20일

QC 기준을 충족하는 마지막 업데이트 제출

2022년 7월 19일

마지막으로 확인됨

2022년 7월 1일

추가 정보

이 연구와 관련된 용어

개별 참가자 데이터(IPD) 계획

개별 참가자 데이터(IPD)를 공유할 계획입니까?

아니요

약물 및 장치 정보, 연구 문서

미국 FDA 규제 의약품 연구

아니

미국 FDA 규제 기기 제품 연구

아니

이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .

3
구독하다